Celltrion
068270.KS
#859
Rank
HK$212.06 B
Marketcap
HK$969.32
Share price
-1.10%
Change (1 day)
4.12%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): HK$14.75

According to Celltrion 's latest financial reports the company's current EPS (TTM) is HK$14.72. In 2023 the company made an earnings per share (EPS) of HK$21.51 a decrease over its 2022 EPS that were of HK$21.96.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$14.75
2023HK$21.51-2.08%
2022HK$21.96-11.72%
2021HK$24.882.03%
2020HK$24.3882.8%
2019HK$13.3418.31%
2018HK$11.27-36.33%
2017HK$17.71161.25%
2016HK$6.782.86%
2015HK$6.5917.84%
2014HK$5.595.87%
2013HK$5.28-70.85%
2012HK$18.12134.09%
2011HK$7.7443.59%
2010HK$5.3974.49%
2009HK$3.09317.8%
2008HK$0.74-71.7%
2007HK$2.61